Skip to main content

Cardinal Health cash flow statement

  • CAH · NYSE
  • Distribution
  • Health Care Distributors
  • S&P 500
$281.10+1.06%Close 13 Nov 2026 · Market value $65.45B

In fiscal 2026 (the year to 30 Jun 2026), Cardinal Health generated $5.17B of operating cash flow and $4.53B of free cash flow, after $649.0M of capital expenditure.

From Cardinal Health's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 30 Jun 2026. TTM is the last four reported quarters added up.

Annual

Cardinal Health cash flow statement, annual
USDFY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026TTM
Net income$1.15B$642.0M$959.0M$1.07B$334.0M$1.17B$1.22B$1.43B$1.29B$256.0M$1.36B−$3.70B$611.0M−$938.0M$330.0M$852.0M$1.56B$1.71B$1.82B
Depreciation & amortization$225.8M$254.0M$313.0M$325.0M$397.0M$459.0M$451.0M$641.0M$717.0M$1.03B$1.00B$913.0M$783.0M$692.0M$692.0M$710.0M$790.0M$956.0M$970.0M
Stock-based compensation$109.9M$100.0M$80.00M$85.00M$93.00M$96.00M$110.0M$111.0M$96.00M$85.00M$82.00M$90.00M$89.00M$81.00M$96.00M$121.0M$244.0M$367.0M$383.0M
Operating cash flow$1.42B$2.13B$1.40B$1.18B$1.73B$2.52B$2.54B$2.97B$1.18B$2.77B$2.72B$1.96B$2.43B$3.17B$2.84B$3.76B$2.40B$5.17B$5.60B
Operating cash flow margin1.5%2.2%1.4%1.1%1.7%2.8%2.5%2.4%0.9%2.0%1.9%1.3%1.5%1.8%1.4%1.7%1.1%2.0%2.2%
Capital expenditures$421.2M$260.0M$291.0M$260.0M$195.0M$249.0M$300.0M$465.0M$387.0M$384.0M$328.0M$375.0M$400.0M$387.0M$481.0M$511.0M$547.0M$649.0M$698.0M
Acquisitions$128.6M$32.00M$2.30B$174.0M$2.24B$519.0M$503.0M$3.61B$132.0M$6.14B$82.00M$0.00$3.00M$22.00M$10.00M$1.19B$5.25B$1.99B$2.10B
Free cash flow$1.00B$1.87B$1.10B$916.0M$1.53B$2.27B$2.24B$2.51B$797.0M$2.38B$2.39B$1.58B$2.03B$2.79B$2.36B$3.25B$1.85B$4.53B$4.90B
Free cash flow margin1.0%1.9%1.1%0.9%1.5%2.5%2.2%2.1%0.6%1.7%1.6%1.0%1.2%1.5%1.2%1.4%0.8%1.8%1.9%
Free cash flow per share$2.77$5.19$3.13$2.62$4.45$6.59$6.69$7.59$2.49$7.57$7.95$5.41$6.90$9.99$9.02$13.16$7.64$19.09$20.85
Dividends paid$200.4M$253.0M$274.0M$300.0M$353.0M$415.0M$460.0M$512.0M$577.0M$581.0M$577.0M$569.0M$573.0M$559.0M$525.0M$499.0M$494.0M$491.0M$488.0M
Gross share repurchases$0.00$230.0M$270.0M$450.0M$450.0M$673.0M$1.04B$651.0M$600.0M$550.0M$600.0M$350.0M$200.0M$1.00B$2.00B$750.0M$765.0M$1.36B$1.48B
Stock issuance proceeds$39.20M$40.00M$63.00M$42.00M———————————————
Net share repurchases−$39.20M$190.0M$207.0M$408.0M$450.0M$673.0M$1.04B$651.0M$600.0M$550.0M$600.0M$350.0M$200.0M$1.00B$2.00B$750.0M$765.0M$1.36B$1.48B
Cash interest paid$201.8M$158.0M$116.0M$118.0M$128.0M$152.0M$150.0M$174.0M$200.0M$320.0M$285.0M$226.0M$182.0M$153.0M$203.0M$214.0M$315.0M$406.0M—
Free cash flow after SBC$892.8M$1.77B$1.02B$831.0M$1.44B$2.18B$2.13B$2.40B$701.0M$2.30B$2.31B$1.50B$1.94B$2.71B$2.27B$3.13B$1.61B$4.16B$4.52B

Quarterly

Cardinal Health cash flow statement, quarterly
USDQ2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Net income$368.0M$261.0M$235.0M$416.0M$400.0M$506.0M$239.0M$450.0M$467.0M$399.0M$398.0M$554.0M
Depreciation & amortization$175.0M$177.0M$186.0M$182.0M$192.0M$207.0M$209.0M$233.0M$234.0M$248.0M$241.0M$247.0M
Stock-based compensation$28.00M$31.00M$33.00M$30.00M$30.00M$31.00M$153.0M$93.00M$87.00M$129.0M$58.00M$109.0M
Operating cash flow$1.18B−$27.00M$2.08B−$1.65B−$396.0M$2.92B$1.52B$973.0M$686.0M$1.82B$1.69B$1.40B
Operating cash flow margin2.1%0.0%3.5%−3.2%−0.7%5.3%2.5%1.5%1.0%3.0%2.7%2.1%
Capital expenditures$114.0M$112.0M$193.0M$90.00M$99.00M$126.0M$232.0M$108.0M$131.0M$146.0M$264.0M$157.0M
Acquisitions—$1.19B$2.00M$0.00$1.08B$2.78B$1.40B$41.00M$1.88B$42.00M$24.00M$149.0M
Free cash flow$1.06B−$139.0M$1.89B−$1.74B−$495.0M$2.79B$1.29B$865.0M$555.0M$1.68B$1.43B$1.24B
Free cash flow margin1.9%−0.3%3.2%−3.3%−0.9%5.1%2.1%1.4%0.8%2.8%2.2%1.8%
Free cash flow per share$4.33−$0.57$7.65−$7.09−$2.04$11.59$5.39$3.62$2.34$7.11$6.10$5.33
Dividends paid$124.0M$122.0M$122.0M$128.0M$122.0M$124.0M$120.0M$129.0M$122.0M$120.0M$120.0M$126.0M
Gross share repurchases$250.0M$0.00$0.00$375.0M$15.00M$375.0M$0.00$375.0M$383.0M$250.0M$350.0M$500.0M
Net share repurchases$250.0M$0.00$0.00$375.0M$15.00M$375.0M$0.00$375.0M$383.0M$250.0M$350.0M$500.0M
Free cash flow after SBC$1.04B−$170.0M$1.86B−$1.77B−$525.0M$2.76B$1.14B$772.0M$468.0M$1.55B$1.37B$1.13B

The main figures as JSON and plain text. See data and methodology.

CAH in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.